Haddadin Yezan Munther - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Mar 28, 2024, Haddadin Yezan Munther's relationship to Outlook Therapeutics, Inc. (OTLK) is Director, and currently has 5,048.71 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OTLK insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Haddadin Yezan Munther - Insider Non-Derivative Transactions of OTLK Common Stock

Haddadin Yezan Munther - Insider Non-Derivative Transactions at OTLK

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Mar 29, 2024	P -- (Common Stock)	1881.71	11.82	5048.71